BR112018072498A2 - marcadores de câncer do endométrio - Google Patents

marcadores de câncer do endométrio

Info

Publication number
BR112018072498A2
BR112018072498A2 BR112018072498A BR112018072498A BR112018072498A2 BR 112018072498 A2 BR112018072498 A2 BR 112018072498A2 BR 112018072498 A BR112018072498 A BR 112018072498A BR 112018072498 A BR112018072498 A BR 112018072498A BR 112018072498 A2 BR112018072498 A2 BR 112018072498A2
Authority
BR
Brazil
Prior art keywords
endometrial cancer
cancer markers
diagnosing
present
mmp9
Prior art date
Application number
BR112018072498A
Other languages
English (en)
Portuguese (pt)
Inventor
Lesur Antoine
gil moreno Antonio
Domon Bruno
Martinez García Elena
Colás Ortega Eva
Reventós Puigjaner Jaume
Original Assignee
Fundacio Hospital Univ Vall Dhebron Institut De Recerca
Inst De Recerca Biomedica De Lleida Fundacio Dr Pifarre
Luxembourg Inst Of Health Lih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Hospital Univ Vall Dhebron Institut De Recerca, Inst De Recerca Biomedica De Lleida Fundacio Dr Pifarre, Luxembourg Inst Of Health Lih filed Critical Fundacio Hospital Univ Vall Dhebron Institut De Recerca
Publication of BR112018072498A2 publication Critical patent/BR112018072498A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57442Specifically defined cancers of the uterus and endometrial
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/908Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • G01N2333/96491Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494Matrix metalloproteases, e. g. 3.4.24.7
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112018072498A 2016-05-04 2017-03-30 marcadores de câncer do endométrio BR112018072498A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16168328 2016-05-04
PCT/EP2017/057635 WO2017190896A1 (en) 2016-05-04 2017-03-30 Mmp9 as marker of endometrial cancer

Publications (1)

Publication Number Publication Date
BR112018072498A2 true BR112018072498A2 (pt) 2019-03-12

Family

ID=56096908

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018072498A BR112018072498A2 (pt) 2016-05-04 2017-03-30 marcadores de câncer do endométrio

Country Status (12)

Country Link
US (2) US20190137499A1 (enExample)
EP (3) EP3452829B1 (enExample)
JP (3) JP7240712B2 (enExample)
AU (3) AU2017260806B9 (enExample)
BR (1) BR112018072498A2 (enExample)
CA (2) CA3286798A1 (enExample)
DK (1) DK3452829T3 (enExample)
ES (1) ES2974307T3 (enExample)
FI (1) FI3452829T3 (enExample)
PL (1) PL3452829T3 (enExample)
PT (1) PT3452829T (enExample)
WO (1) WO2017190896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3655778T (pt) * 2017-07-21 2023-08-18 Fundacio Hospital Univ Vall Dhebron Institut De Recerca Agrin como marcador de cancro do endométrio
EP4373973A1 (en) 2021-07-23 2024-05-29 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Biomarkers for endometrial cancer
CN113493838B (zh) * 2021-09-06 2021-11-23 北京泱深生物信息技术有限公司 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用
KR102640230B1 (ko) * 2021-09-24 2024-02-22 가천대학교 산학협력단 C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
WO2005061725A1 (en) * 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase
US20080090258A1 (en) 2006-06-28 2008-04-17 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
US8329399B2 (en) * 2006-10-27 2012-12-11 Siu K W Michael Endometrial biomarkers
IN2012DN00707A (enExample) 2009-07-24 2015-06-19 Geadic Biotec Aie

Also Published As

Publication number Publication date
US20230221323A1 (en) 2023-07-13
JP7492287B2 (ja) 2024-05-29
EP4610655A3 (en) 2025-12-10
JP7240712B2 (ja) 2023-03-16
CA3286798A1 (en) 2025-10-30
AU2017260806B2 (en) 2023-06-15
AU2023210591B2 (en) 2025-06-26
AU2023210591B9 (en) 2025-07-10
AU2017260806B9 (en) 2023-07-20
CA3022586A1 (en) 2017-11-09
JP2019516104A (ja) 2019-06-13
PT3452829T (pt) 2024-03-22
ES2974307T3 (es) 2024-06-26
EP3452829A1 (en) 2019-03-13
PL3452829T3 (pl) 2024-05-20
EP4610655A2 (en) 2025-09-03
EP4180814A3 (en) 2023-07-12
EP3452829B1 (en) 2024-01-24
JP2024116127A (ja) 2024-08-27
US20190137499A1 (en) 2019-05-09
AU2023210591A1 (en) 2023-08-24
JP2023040246A (ja) 2023-03-22
FI3452829T3 (fi) 2024-03-20
AU2025223935A1 (en) 2025-09-18
WO2017190896A1 (en) 2017-11-09
DK3452829T3 (da) 2024-03-25
AU2017260806A1 (en) 2018-12-13
EP4180814A2 (en) 2023-05-17

Similar Documents

Publication Publication Date Title
BR112018072498A2 (pt) marcadores de câncer do endométrio
BR112016027939B8 (pt) Sistemas e métodos incluindo uma válvula rotativa para pelo menos um entre preparação de amostra ou análise de amostra
MX2017008421A (es) Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga.
EP3640341A3 (en) Assays to determine dna methylation and dna methylation markers of cancer
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
GB2556004A (en) Markers of stroke and stroke severity
BR112016007864A2 (pt) método para a prognose e tratamento de metástase de câncer
CO2019002607A2 (es) Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activación por contacto
BR112016002845A2 (pt) composições e métodos para tratar condições associadas ao complemento
BR112015015086A2 (pt) calibração de válvula de fluido acústico
EP3165923A4 (en) Marker, immunoassay method, immunoassay reagent, method for assaying analyte, kit for assaying analyte, and test strip for lateral flow chromatography
CO2019011359A2 (es) Sistema para predecir el pronóstico y beneficio de una quimioterapia adyuvante para pacientes con cáncer gástrico en estadio ii y iii
BR112019000316A2 (pt) detecção de fluxo de fluido
BR112018067990A2 (pt) cromogranina a como um marcador para câncer de bexiga
MX392040B (es) Estandares de antigeno prostatico y sus usos.
EP4220171A3 (en) Markers for endometrial cancer
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
UY36200A (es) Conjunto de biomarcadores específicos para diagnóstico no invasivo de cáncer de hígado
BR112019005172A2 (pt) método e kit para analisar uma amostra
EP4513187A3 (en) Methods of detecting prostate cancer
MX374415B (es) Composiciones y métodos para identificar un riesgo de cáncer en un sujeto.
BR112019001712A2 (pt) uso de um biomarcador, e, método para avaliar se o indivíduo tem um carcinoma
BR112016029562A2 (pt) métodos para tratar, diagnosticar e prognosticar uma malignidade hematológica
EA201891170A1 (ru) Биомаркер поликистозной болезни почек и варианты его применения
MX2024009782A (es) Biomarcadores proteicos para enfermedades asociadas con el sistema de activacion por contacto.

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (ES)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122023026792-3 PROTOCOLO 870230111943 EM 19/12/2023 11:37.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122025014970-5 PROTOCOLO 870250062108 EM 18/07/2025 17:05.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/03/2017, OBSERVADAS AS CONDICOES LEGAIS